1. Home
  2. SVC vs RIGL Comparison

SVC vs RIGL Comparison

Compare SVC & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVC
  • RIGL
  • Stock Information
  • Founded
  • SVC 1995
  • RIGL 1996
  • Country
  • SVC United States
  • RIGL United States
  • Employees
  • SVC N/A
  • RIGL N/A
  • Industry
  • SVC Real Estate Investment Trusts
  • RIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • SVC Real Estate
  • RIGL Health Care
  • Exchange
  • SVC Nasdaq
  • RIGL Nasdaq
  • Market Cap
  • SVC 453.3M
  • RIGL 486.4M
  • IPO Year
  • SVC N/A
  • RIGL 2000
  • Fundamental
  • Price
  • SVC $2.69
  • RIGL $20.09
  • Analyst Decision
  • SVC Buy
  • RIGL Buy
  • Analyst Count
  • SVC 2
  • RIGL 5
  • Target Price
  • SVC $5.25
  • RIGL $34.80
  • AVG Volume (30 Days)
  • SVC 1.5M
  • RIGL 226.6K
  • Earning Date
  • SVC 02-26-2025
  • RIGL 03-04-2025
  • Dividend Yield
  • SVC 1.49%
  • RIGL N/A
  • EPS Growth
  • SVC N/A
  • RIGL N/A
  • EPS
  • SVC N/A
  • RIGL 0.22
  • Revenue
  • SVC $1,884,419,000.00
  • RIGL $157,374,000.00
  • Revenue This Year
  • SVC N/A
  • RIGL $51.34
  • Revenue Next Year
  • SVC N/A
  • RIGL $15.75
  • P/E Ratio
  • SVC N/A
  • RIGL $90.73
  • Revenue Growth
  • SVC N/A
  • RIGL 21.65
  • 52 Week Low
  • SVC $2.29
  • RIGL $7.48
  • 52 Week High
  • SVC $7.73
  • RIGL $29.82
  • Technical
  • Relative Strength Index (RSI)
  • SVC 48.69
  • RIGL 45.75
  • Support Level
  • SVC $2.55
  • RIGL $20.00
  • Resistance Level
  • SVC $2.69
  • RIGL $21.93
  • Average True Range (ATR)
  • SVC 0.13
  • RIGL 1.30
  • MACD
  • SVC -0.01
  • RIGL -0.27
  • Stochastic Oscillator
  • SVC 43.24
  • RIGL 2.01

About SVC Service Properties Trust

Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its hotel investment unit and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza Hotels & Resorts, and Hyatt Place.

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Share on Social Networks: